Australia Launches National Review of Transgender Healthcare for Youth
The federal government tasks its peak medical body with developing evidence-based guidelines for gender-affirming care, urging Queensland to align with national standards.
- Federal Health Minister Mark Butler announced a review of treatment guidelines for transgender and gender-diverse children and adolescents in Australia.
- The National Health and Medical Research Council (NHMRC) will lead the review, focusing on puberty blockers and hormone therapies, with interim advice on puberty blockers expected by mid-2026.
- The review aims to establish consistent, evidence-based national standards, replacing state-level variations in care for young people with gender dysphoria.
- Queensland recently paused new prescriptions of puberty blockers and hormone therapies for minors, a move criticized by advocates and deemed inappropriate by the federal health minister.
- LGBTIQ+ health groups cautiously welcomed the review, emphasizing the need for expert-led, evidence-based processes free from political interference.